Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations

PurposeTo explore the benefit of adaptive magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) for treatment of lung tumors in different locations with a focus on ultracentral lung tumors (ULT).Patients & MethodsA prospective cohort of 21 patients with 23 primary and secondary lung...

Full description

Saved in:
Bibliographic Details
Main Authors: Regnery, Sebastian (Author) , Buchele, Carolin (Author) , Weykamp, Fabian (Author) , Pohl, Moritz (Author) , Hoegen-Saßmannshausen, Philipp (Author) , Eichkorn, Tanja (Author) , Held, Thomas (Author) , Ristau, Jonas (Author) , Rippke, Carolin (Author) , König, Laila (Author) , Thomas, Michael (Author) , Winter, Hauke (Author) , Adeberg, Sebastian (Author) , Debus, Jürgen (Author) , Klüter, Sebastian (Author) , Hörner-Rieber, Juliane (Author)
Format: Article (Journal)
Language:English
Published: 2022
In: Frontiers in oncology
Year: 2022, Volume: 11, Pages: 1-10
ISSN:2234-943X
DOI:10.3389/fonc.2021.757031
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fonc.2021.757031
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fonc.2021.757031/full
Get full text
Author Notes:Sebastian Regnery, Carolin Buchele, Fabian Weykamp, Moritz Pohl, Philipp Hoegen, Tanja Eichkorn, Thomas Held, Jonas Ristau, Carolin Rippke, Laila König, Michael Thomas, Hauke Winter, Sebastian Adeberg, Jürgen Debus, Sebastian Klüter and Juliane Hörner-Rieber

MARC

LEADER 00000caa a2200000 c 4500
001 1789950430
003 DE-627
005 20230525084002.0
007 cr uuu---uuuuu
008 220217s2022 xx |||||o 00| ||eng c
024 7 |a 10.3389/fonc.2021.757031  |2 doi 
035 |a (DE-627)1789950430 
035 |a (DE-599)KXP1789950430 
035 |a (OCoLC)1341441888 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Regnery, Sebastian  |e VerfasserIn  |0 (DE-588)1182554776  |0 (DE-627)1662804199  |4 aut 
245 1 0 |a Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations  |c Sebastian Regnery, Carolin Buchele, Fabian Weykamp, Moritz Pohl, Philipp Hoegen, Tanja Eichkorn, Thomas Held, Jonas Ristau, Carolin Rippke, Laila König, Michael Thomas, Hauke Winter, Sebastian Adeberg, Jürgen Debus, Sebastian Klüter and Juliane Hörner-Rieber 
264 1 |c 2022 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.02.2022 
520 |a PurposeTo explore the benefit of adaptive magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) for treatment of lung tumors in different locations with a focus on ultracentral lung tumors (ULT).Patients & MethodsA prospective cohort of 21 patients with 23 primary and secondary lung tumors was analyzed. Tumors were located peripherally (N = 10), centrally (N = 2) and ultracentrally (N = 11, planning target volume (PTV) overlap with proximal bronchi, esophagus and/or pulmonary artery). All patients received MRgSBRT with gated dose delivery and risk-adapted fractionation. Before each fraction, the baseline plan was recalculated on the anatomy of the day (predicted plan). Plan adaptation was performed in 154/165 fractions (93.3%). Comparison of dose characteristics between predicted and adapted plans employed descriptive statistics and Bayesian linear multilevel models. The posterior distributions resulting from the Bayesian models are presented by the mean together with the corresponding 95% compatibility interval (CI).ResultsPlan adaptation decreased the proportion of fractions with violated planning objectives from 94% (predicted plans) to 17% (adapted plans). In most cases, inadequate PTV coverage was remedied (predicted: 86%, adapted: 13%), corresponding to a moderate increase of PTV coverage (mean +6.3%, 95% CI: [5.3-7.4%]) and biologically effective PTV doses (BED10) (BEDmin: +9.0 Gy [6.7-11.3 Gy], BEDmean: +1.4 Gy [0.8-2.1 Gy]). This benefit was smaller in larger tumors (−0.1%/10 cm³ PTV [−0.2 to −0.02%/10 cm³ PTV]) and ULT (−2.0% [−3.1 to −0.9%]). Occurrence of exceeded maximum doses inside the PTV (predicted: 21%, adapted: 4%) and violations of OAR constraints (predicted: 12%, adapted: 1%, OR: 0.14 [0.04-0.44]) was effectively reduced. OAR constraint violations almost exclusively occurred if the PTV had touched the corresponding OAR in the baseline plan (18/19, 95%).ConclusionAdaptive MRgSBRT is highly recommendable for ablative treatment of lung tumors whose PTV initially contacts a sensitive OAR, such as ULT. Here, plan adaptation protects the OAR while maintaining best-possible PTV coverage. 
700 1 |a Buchele, Carolin  |d 1992-  |e VerfasserIn  |0 (DE-588)1238773230  |0 (DE-627)1766395635  |4 aut 
700 1 |a Weykamp, Fabian  |d 1987-  |e VerfasserIn  |0 (DE-588)1072433036  |0 (DE-627)827655096  |0 (DE-576)43385992X  |4 aut 
700 1 |a Pohl, Moritz  |d 1991-  |e VerfasserIn  |0 (DE-588)1203763018  |0 (DE-627)1688817549  |4 aut 
700 1 |a Hoegen-Saßmannshausen, Philipp  |d 1987-  |e VerfasserIn  |0 (DE-588)1162715278  |0 (DE-627)1026887836  |0 (DE-576)507591283  |4 aut 
700 1 |a Eichkorn, Tanja  |e VerfasserIn  |0 (DE-588)1191801187  |0 (DE-627)167027666X  |4 aut 
700 1 |a Held, Thomas  |d 1990-  |e VerfasserIn  |0 (DE-588)1172053723  |0 (DE-627)104086970X  |0 (DE-576)513977627  |4 aut 
700 1 |a Ristau, Jonas  |d 1989-  |e VerfasserIn  |0 (DE-588)1075216303  |0 (DE-627)83302986X  |0 (DE-576)443326444  |4 aut 
700 1 |a Rippke, Carolin  |d 1993-  |e VerfasserIn  |0 (DE-588)1238772773  |0 (DE-627)1766392539  |4 aut 
700 1 |a König, Laila  |d 1986-  |e VerfasserIn  |0 (DE-588)1053640579  |0 (DE-627)790403315  |0 (DE-576)409584282  |4 aut 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
700 1 |a Winter, Hauke  |e VerfasserIn  |0 (DE-588)1162076038  |0 (DE-627)1025509773  |0 (DE-576)176791531  |4 aut 
700 1 |a Adeberg, Sebastian  |d 1984-  |e VerfasserIn  |0 (DE-588)1049743377  |0 (DE-627)782574467  |0 (DE-576)403727774  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Klüter, Sebastian  |d 1980-  |e VerfasserIn  |0 (DE-588)1071160796  |0 (DE-627)825622646  |0 (DE-576)311255248  |4 aut 
700 1 |a Hörner-Rieber, Juliane  |d 1985-  |e VerfasserIn  |0 (DE-588)1025307631  |0 (DE-627)722020511  |0 (DE-576)370188039  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in oncology  |d Lausanne : Frontiers Media, 2011  |g 11(2022) vom: 11. Jan., Artikel-ID 757031, Seite 1-10  |h Online-Ressource  |w (DE-627)684965518  |w (DE-600)2649216-7  |w (DE-576)35841184X  |x 2234-943X  |7 nnas  |a Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations 
773 1 8 |g volume:11  |g year:2022  |g day:11  |g month:01  |g elocationid:757031  |g pages:1-10  |g extent:10  |a Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations 
856 4 0 |u https://doi.org/10.3389/fonc.2021.757031  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fonc.2021.757031/full  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20220217 
993 |a Article 
994 |a 2022 
998 |g 1025307631  |a Hörner-Rieber, Juliane  |m 1025307631:Hörner-Rieber, Juliane  |d 910000  |d 911400  |d 50000  |e 910000PH1025307631  |e 911400PH1025307631  |e 50000PH1025307631  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 16  |y j 
998 |g 1071160796  |a Klüter, Sebastian  |m 1071160796:Klüter, Sebastian  |d 910000  |d 911400  |e 910000PK1071160796  |e 911400PK1071160796  |k 0/910000/  |k 1/910000/911400/  |p 15 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 14 
998 |g 1049743377  |a Adeberg, Sebastian  |m 1049743377:Adeberg, Sebastian  |d 910000  |d 911400  |d 50000  |e 910000PA1049743377  |e 911400PA1049743377  |e 50000PA1049743377  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 13 
998 |g 1162076038  |a Winter, Hauke  |m 1162076038:Winter, Hauke  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PW1162076038  |e 950000PW1162076038  |e 950900PW1162076038  |e 50000PW1162076038  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 12 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |e 50000PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 11 
998 |g 1053640579  |a König, Laila  |m 1053640579:König, Laila  |d 910000  |d 911400  |e 910000PK1053640579  |e 911400PK1053640579  |k 0/910000/  |k 1/910000/911400/  |p 10 
998 |g 1238772773  |a Rippke, Carolin  |m 1238772773:Rippke, Carolin  |d 910000  |d 911400  |e 910000PR1238772773  |e 911400PR1238772773  |k 0/910000/  |k 1/910000/911400/  |p 9 
998 |g 1075216303  |a Ristau, Jonas  |m 1075216303:Ristau, Jonas  |d 910000  |d 911400  |e 910000PR1075216303  |e 911400PR1075216303  |k 0/910000/  |k 1/910000/911400/  |p 8 
998 |g 1172053723  |a Held, Thomas  |m 1172053723:Held, Thomas  |d 910000  |d 911400  |e 910000PH1172053723  |e 911400PH1172053723  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 1191801187  |a Eichkorn, Tanja  |m 1191801187:Eichkorn, Tanja  |d 910000  |d 911400  |e 910000PE1191801187  |e 911400PE1191801187  |k 0/910000/  |k 1/910000/911400/  |p 6 
998 |g 1162715278  |a Hoegen-Saßmannshausen, Philipp  |m 1162715278:Hoegen-Saßmannshausen, Philipp  |d 910000  |d 911400  |e 910000PH1162715278  |e 911400PH1162715278  |k 0/910000/  |k 1/910000/911400/  |p 5 
998 |g 1203763018  |a Pohl, Moritz  |m 1203763018:Pohl, Moritz  |d 910000  |d 911800  |e 910000PP1203763018  |e 911800PP1203763018  |k 0/910000/  |k 1/910000/911800/  |p 4 
998 |g 1072433036  |a Weykamp, Fabian  |m 1072433036:Weykamp, Fabian  |d 910000  |d 911400  |e 910000PW1072433036  |e 911400PW1072433036  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 1238773230  |a Buchele, Carolin  |m 1238773230:Buchele, Carolin  |d 910000  |d 911400  |e 910000PB1238773230  |e 911400PB1238773230  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 1182554776  |a Regnery, Sebastian  |m 1182554776:Regnery, Sebastian  |d 910000  |d 911400  |e 910000PR1182554776  |e 911400PR1182554776  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1789950430  |e 4061037145 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 17.02.2022"],"origin":[{"dateIssuedDisp":"2022","dateIssuedKey":"2022"}],"recId":"1789950430","relHost":[{"part":{"volume":"11","extent":"10","year":"2022","pages":"1-10","text":"11(2022) vom: 11. Jan., Artikel-ID 757031, Seite 1-10"},"title":[{"title_sort":"Frontiers in oncology","title":"Frontiers in oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locationsFrontiers in oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["2234-943X"],"eki":["684965518"],"zdb":["2649216-7"]},"language":["eng"],"recId":"684965518","origin":[{"publisher":"Frontiers Media","dateIssuedDisp":"2011-","dateIssuedKey":"2011","publisherPlace":"Lausanne"}],"note":["Gesehen am 07.11.13"],"pubHistory":["2011 -"]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"name":{"displayForm":["Sebastian Regnery, Carolin Buchele, Fabian Weykamp, Moritz Pohl, Philipp Hoegen, Tanja Eichkorn, Thomas Held, Jonas Ristau, Carolin Rippke, Laila König, Michael Thomas, Hauke Winter, Sebastian Adeberg, Jürgen Debus, Sebastian Klüter and Juliane Hörner-Rieber"]},"title":[{"title_sort":"Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations","title":"Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations"}],"person":[{"family":"Regnery","role":"aut","given":"Sebastian","display":"Regnery, Sebastian"},{"role":"aut","display":"Buchele, Carolin","given":"Carolin","family":"Buchele"},{"family":"Weykamp","display":"Weykamp, Fabian","given":"Fabian","role":"aut"},{"family":"Pohl","given":"Moritz","display":"Pohl, Moritz","role":"aut"},{"role":"aut","display":"Hoegen-Saßmannshausen, Philipp","given":"Philipp","family":"Hoegen-Saßmannshausen"},{"role":"aut","display":"Eichkorn, Tanja","given":"Tanja","family":"Eichkorn"},{"display":"Held, Thomas","given":"Thomas","role":"aut","family":"Held"},{"family":"Ristau","role":"aut","display":"Ristau, Jonas","given":"Jonas"},{"family":"Rippke","role":"aut","given":"Carolin","display":"Rippke, Carolin"},{"family":"König","role":"aut","display":"König, Laila","given":"Laila"},{"family":"Thomas","role":"aut","given":"Michael","display":"Thomas, Michael"},{"given":"Hauke","display":"Winter, Hauke","role":"aut","family":"Winter"},{"given":"Sebastian","display":"Adeberg, Sebastian","role":"aut","family":"Adeberg"},{"role":"aut","given":"Jürgen","display":"Debus, Jürgen","family":"Debus"},{"family":"Klüter","role":"aut","display":"Klüter, Sebastian","given":"Sebastian"},{"family":"Hörner-Rieber","given":"Juliane","display":"Hörner-Rieber, Juliane","role":"aut"}],"id":{"doi":["10.3389/fonc.2021.757031"],"eki":["1789950430"]},"physDesc":[{"extent":"10 S."}]} 
SRT |a REGNERYSEBADAPTIVEMR2022